Proteins.1
PrivateLast Round
Pre Seed
Apr 16, 2026
Total Funding Raised
$5.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Proteins.1 is a Finnish deeptech diagnostics company that develops a patented, physics-based single-molecule protein amplification platform for ultra-sensitive detection of biomarkers.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Biotech Equipment, Medical Devices, Precision Medicine
Business Model
B2B
Customer Profile
Hardware Sales, Usage-Based SaaS, Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Proteins.1 Comparables
Compare Proteins.1 with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Thermo Fisher Scientific Inc. | 76% | |
| Alamar Biosciences | 74% | |
| Nautilus Biotechnology | 73% |
Proteins.1 Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Pre Seed | Apr 16, 2026 |
Proteins.1 Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Business Finland | Pre Seed |
| Lifeline Ventures | Pre Seed |
| VTT Holding | Pre Seed |
| Cloudberry Ventures | Pre Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
Raised $5.54M in a Pre Seed round.
Proteins.1 Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request access